Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Obstetrics & Gynecology 1983;61:486-492
© 1983 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WILSON, S. J.
Right arrow Articles by ERRICK, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WILSON, S. J.
Right arrow Articles by ERRICK, J. K.

Pharmacokinetic and Hemodynamic Effects of Caffeine in the Pregnant Sheep

STEPHEN J. WILSON, MD, JAHANGIR AYROMLOOI, MD and JEFFREY KEITH ERRICK, PharmD

From the Department of Obstetrics and Gynecology, Long Island Jewish-Hillside Medical Center, State University of New York at Stony Brook School of Medicine, New Hyde Park; and St. John's University, College of Pharmacy and Allied Health Professions, Jamaica, New York

Abstract

Caffeine citrate in doses of 6.96 mg/kg (equivalent to 3.50 mg/kg of caffeine) of combined maternal and fetal weight and 69.6 mg/kg (35.0 mg/kg of caffeine) was administered in 1-dl solutions intravenously over ten minutes to chronically prepared pregnant sheep. The ewes and their fetuses were monitored for cardiovascular and acid-base status. The mean maternal and fetal caffeine concentrations were simultaneously evaluated with a two-compartment pharmacokinetic model. Fetal concentrations in excess of 80% of maternal concentrations were rapidly achieved and maintained. Caffeine was undetectable in all the maternal and fetal samples obtained 48 hours after the infusion. Both doses caused similar but slight reductions in uterine blood flow without adversely affecting fetal and maternal acid-base status. Only the higher concentration of the drug produced a significant maternal and fetal tachycardia. The high fetal concentrations of caffeine were believed to be responsible for the persistent fetal tachycardia.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
N. Momoi, J. P. Tinney, L. J. Liu, H. Elshershari, P. J. Hoffmann, J. C. Ralphe, B. B. Keller, and K. Tobita
Modest maternal caffeine exposure affects developing embryonic cardiovascular function and growth
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2248 - H2256.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
T. Tomimatsu, S. J. Lee, J. Pereyra Pena, J. M. Ross, J. A. Lang, and L. D. Longo
Maternal Caffeine Administration and Cerebral Oxygenation in Near-Term Fetal Sheep
Reproductive Sciences, September 1, 2007; 14(6): 588 - 594.
[Abstract] [PDF]

Home page
 J. Appl. Physiol.Home page
C. J. Plaskett and E. Cafarelli
Caffeine increases endurance and attenuates force sensation during submaximal isometric contractions
J Appl Physiol, October 1, 2001; 91(4): 1535 - 1544.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
A. Hadeed and S. Siegel
Newborn Cardiac Arrhythmias Associated With Maternal Caffeine Use During Pregnancy
Clinical Pediatrics, January 1, 1993; 32(1): 45 - 47.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American College of Obstetricians and Gynecologists.